Heron Therapeutics, Inc. (HRTX)
0.3266
-0.01
(-1.66%)
USD |
NASDAQ |
Aug 28, 16:00
0.3242
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Cash and Short Term Investments (Quarterly) : 42.66M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 42.66M |
| March 31, 2026 | 44.78M |
| December 31, 2025 | 46.63M |
| September 30, 2025 | 55.49M |
| June 30, 2025 | 40.63M |
| March 31, 2025 | 50.68M |
| December 31, 2024 | 59.28M |
| September 30, 2024 | 70.89M |
| June 30, 2024 | 67.35M |
| March 31, 2024 | 71.52M |
| December 31, 2023 | 80.41M |
| September 30, 2023 | 77.41M |
| June 30, 2023 | 33.24M |
| March 31, 2023 | 60.02M |
| December 31, 2022 | 84.85M |
| September 30, 2022 | 121.75M |
| June 30, 2022 | 83.54M |
| March 31, 2022 | 111.91M |
| December 31, 2021 | 157.58M |
| September 30, 2021 | 202.82M |
| June 30, 2021 | 257.68M |
| March 31, 2021 | 166.47M |
| December 31, 2020 | 208.49M |
| September 30, 2020 | 258.15M |
| June 30, 2020 | 300.84M |
| Date | Value |
|---|---|
| March 31, 2020 | 356.35M |
| December 31, 2019 | 390.97M |
| September 30, 2019 | 256.28M |
| June 30, 2019 | 276.00M |
| March 31, 2019 | 289.24M |
| December 31, 2018 | 332.37M |
| September 30, 2018 | 364.80M |
| June 30, 2018 | 422.96M |
| March 31, 2018 | 113.94M |
| December 31, 2017 | 172.38M |
| September 30, 2017 | 74.02M |
| June 30, 2017 | 109.26M |
| March 31, 2017 | 165.22M |
| December 31, 2016 | 51.14M |
| September 30, 2016 | 88.92M |
| June 30, 2016 | 74.64M |
| March 31, 2016 | 100.41M |
| December 31, 2015 | 131.17M |
| September 30, 2015 | 152.99M |
| June 30, 2015 | 171.53M |
| March 31, 2015 | 55.56M |
| December 31, 2014 | 72.68M |
| September 30, 2014 | 86.21M |
| June 30, 2014 | 105.01M |
| March 31, 2014 | 57.48M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Praxis Precision Medicines, Inc. | 758.55M |
| Tonix Pharmaceuticals Holding Corp. | 176.23M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |